Fact CheckerSign in

NCT04395846Active, not recruiting

Heart Failure and Preserved Ejection Fraction: Observation of Its Progression and Prognosis (HOPP-BERN)

Source: ClinicalTrials.gov · Last updated 8 May 2025

Brief summary (registry, in English)

Analysis of longitudinal data, cardiovascular magnetic resonance (CMR) imaging and health related data, of patients with heart failure and preserved ejection fraction (HFpEF) over a timeframe of 5 years per patient. In this study routine clinical data are collected along with additional research parameters measured during CMR. CMR will occur throughout a 5-year follow-up.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
350 (estimated)
First submitted
25 Mar 2020
Start date
2 Mar 2020
Primary completion date
31 Dec 2029
Lead sponsor
Insel Gruppe AG, University Hospital Bern
NCT number
NCT04395846

What you commit to

  • Study type: Observational
  • Planned participants: 350
  • From 2 Mar 2020 to the primary completion date, 31 Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent cardiovascular surgery or intervention (\<90 days)
  • Treatment for chemotherapy or radiotherapy

Other illness

  • Acute myocardial infarction (\<90 days)
  • Severe valve disease
  • Known infiltrative diseases (i.e. amyloidosis, sarcoidosis)
  • Heart transplant

Other

  • MRI incompatibility (ie. pacemakers, ICD, internal defibrillators)
  • Known hypertrophic cardiomyopathy)
  • ARVC (arrhythmogenic right ventricular cardiomyopathy), non-compaction cardiomyopathy
  • Pregnancy

Who the study is looking for

  • Known Heart Failure with Preserved Ejection Fraction (HFpEF) (based on invasive measurement) or high probability of HFpEF (\>70% based on H2FPEF score ≥4)
  • Ability to provide informed consent (knowledge of project languages), \>18 years

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Inselspital, Bern University Hospital
Coordinator of this site? Confirm its status
BernSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.